1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Protein Drug R&D Market Size 2016-2026

2.1.2 Recombinant Protein Drug R&D Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Recombinant Protein Drug R&D Segment by Type

2.2.1 Peptide Hormones

2.2.2 Peptide Hormones

2.2.3 Cytokines

2.2.4 Plasma Protein Factor

2.2.5 Recombinase

2.2.6 Fusion Protein

2.2.7 Other

2.3 Recombinant Protein Drug R&D Market Size by Type

2.3.1 Global Recombinant Protein Drug R&D Market Size CAGR by Type

2.3.2 Global Recombinant Protein Drug R&D Market Size Market Share by Type (2016-2021)

2.4 Recombinant Protein Drug R&D Segment by Application

2.4.1 Diabetes

2.4.2 Dwarfism

2.4.3 Hemophilia

2.4.4 Heart Disease

2.4.5 Cancer

2.4.6 Other

2.5 Recombinant Protein Drug R&D Market Size by Application

2.5.1 Global Recombinant Protein Drug R&D Market Size CAGR by Application

2.5.2 Global Recombinant Protein Drug R&D Market Size Market Share by Application (2016-2021)

3 Recombinant Protein Drug R&D Market Size by Players

3.1 Recombinant Protein Drug R&D Market Size Market Share by Players

3.1.1 Global Recombinant Protein Drug R&D Revenue by Players (2019-2021E)

3.1.2 Global Recombinant Protein Drug R&D Revenue Market Share by Players (2019-2021E)

3.2 Global Recombinant Protein Drug R&D Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Recombinant Protein Drug R&D by Regions

4.1 Recombinant Protein Drug R&D Market Size by Regions (2016-2021)

4.2 Americas Recombinant Protein Drug R&D Market Size Growth (2016-2021)

4.3 APAC Recombinant Protein Drug R&D Market Size Growth (2016-2021)

4.4 Europe Recombinant Protein Drug R&D Market Size Growth (2016-2021)

4.5 Middle East & Africa Recombinant Protein Drug R&D Market Size Growth (2016-2021)

5 Americas

5.1 Americas Recombinant Protein Drug R&D Market Size by Country (2016-2021)

5.2 Americas Recombinant Protein Drug R&D Market Size by Type (2016-2021)

5.3 Americas Recombinant Protein Drug R&D Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Protein Drug R&D Market Size by Region (2016-2021)

6.2 APAC Recombinant Protein Drug R&D Market Size by Type (2016-2021)

6.3 APAC Recombinant Protein Drug R&D Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Recombinant Protein Drug R&D by Country (2016-2021)

7.2 Europe Recombinant Protein Drug R&D Market Size by Type (2016-2021)

7.3 Europe Recombinant Protein Drug R&D Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Protein Drug R&D by Region (2016-2021)

8.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2016-2021)

8.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Recombinant Protein Drug R&D Market Forecast

10.1 Global Recombinant Protein Drug R&D Forecast by Regions (2021-2026)

10.1.1 Global Recombinant Protein Drug R&D Forecast by Regions (2021-2026)

10.1.2 Americas Recombinant Protein Drug R&D Forecast

10.1.3 APAC Recombinant Protein Drug R&D Forecast

10.1.4 Europe Recombinant Protein Drug R&D Forecast

10.1.5 Middle East & Africa Recombinant Protein Drug R&D Forecast

10.2 Americas Recombinant Protein Drug R&D Forecast by Countries (2021-2026)

10.2.1 United States Recombinant Protein Drug R&D Market Forecast

10.2.2 Canada Recombinant Protein Drug R&D Market Forecast

10.2.3 Mexico Recombinant Protein Drug R&D Market Forecast

10.2.4 Brazil Recombinant Protein Drug R&D Market Forecast

10.3 APAC Recombinant Protein Drug R&D Forecast by Region (2021-2026)

10.3.1 China Recombinant Protein Drug R&D Market Forecast

10.3.2 Japan Recombinant Protein Drug R&D Market Forecast

10.3.3 Korea Recombinant Protein Drug R&D Market Forecast

10.3.4 Southeast Asia Recombinant Protein Drug R&D Market Forecast

10.3.5 India Recombinant Protein Drug R&D Market Forecast

10.3.6 Australia Recombinant Protein Drug R&D Market Forecast

10.4 Europe Recombinant Protein Drug R&D Forecast by Country (2021-2026)

10.4.1 Germany Recombinant Protein Drug R&D Market Forecast

10.4.2 France Recombinant Protein Drug R&D Market Forecast

10.4.3 UK Recombinant Protein Drug R&D Market Forecast

10.4.4 Italy Recombinant Protein Drug R&D Market Forecast

10.4.5 Russia Recombinant Protein Drug R&D Market Forecast

10.5 Middle East & Africa Recombinant Protein Drug R&D Forecast by Region (2021-2026)

10.5.1 Egypt Recombinant Protein Drug R&D Market Forecast

10.5.2 South Africa Recombinant Protein Drug R&D Market Forecast

10.5.3 Israel Recombinant Protein Drug R&D Market Forecast

10.5.4 Turkey Recombinant Protein Drug R&D Market Forecast

10.5.5 GCC Countries Recombinant Protein Drug R&D Market Forecast

10.6 Global Recombinant Protein Drug R&D Forecast by Type (2021-2026)

10.8 Global Recombinant Protein Drug R&D Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Recombinant Protein Drug R&D Product Offered

11.1.3 Eli Lilly Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Eli Lilly Main Business Overview

11.1.5 Eli Lilly Latest Developments

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Information

11.2.2 Novo Nordisk Recombinant Protein Drug R&D Product Offered

11.2.3 Novo Nordisk Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Novo Nordisk Main Business Overview

11.2.5 Novo Nordisk Latest Developments

11.3 Amgen

11.3.1 Amgen Company Information

11.3.2 Amgen Recombinant Protein Drug R&D Product Offered

11.3.3 Amgen Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Amgen Main Business Overview

11.3.5 Amgen Latest Developments

11.4 Merck

11.4.1 Merck Company Information

11.4.2 Merck Recombinant Protein Drug R&D Product Offered

11.4.3 Merck Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Merck Main Business Overview

11.4.5 Merck Latest Developments

11.5 Sanofi

11.5.1 Sanofi Company Information

11.5.2 Sanofi Recombinant Protein Drug R&D Product Offered

11.5.3 Sanofi Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Sanofi Main Business Overview

11.5.5 Sanofi Latest Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Recombinant Protein Drug R&D Product Offered

11.6.3 Pfizer Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Pfizer Main Business Overview

11.6.5 Pfizer Latest Developments

11.7 Roche

11.7.1 Roche Company Information

11.7.2 Roche Recombinant Protein Drug R&D Product Offered

11.7.3 Roche Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Roche Main Business Overview

11.7.5 Roche Latest Developments

11.8 Gensci

11.8.1 Gensci Company Information

11.8.2 Gensci Recombinant Protein Drug R&D Product Offered

11.8.3 Gensci Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Gensci Main Business Overview

11.8.5 Gensci Latest Developments

11.9 Ankebio

11.9.1 Ankebio Company Information

11.9.2 Ankebio Recombinant Protein Drug R&D Product Offered

11.9.3 Ankebio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Ankebio Main Business Overview

11.9.5 Ankebio Latest Developments

11.10 United Cell

11.10.1 United Cell Company Information

11.10.2 United Cell Recombinant Protein Drug R&D Product Offered

11.10.3 United Cell Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 United Cell Main Business Overview

11.10.5 United Cell Latest Developments

11. Sinobioway Hygene

11.11.1 Sinobioway Hygene Company Information

11.11.2 Sinobioway Hygene Recombinant Protein Drug R&D Product Offered

11.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Sinobioway Hygene Main Business Overview

11.11.5 Sinobioway Hygene Latest Developments

11.12 Kexing

11.12.1 Kexing Company Information

11.12.2 Kexing Recombinant Protein Drug R&D Product Offered

11.12.3 Kexing Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Kexing Main Business Overview

11.12.5 Kexing Latest Developments

11.13 Dongbao

11.13.1 Dongbao Company Information

11.13.2 Dongbao Recombinant Protein Drug R&D Product Offered

11.13.3 Dongbao Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Dongbao Main Business Overview

11.13.5 Dongbao Latest Developments

11.14 3sbio

11.14.1 3sbio Company Information

11.14.2 3sbio Recombinant Protein Drug R&D Product Offered

11.14.3 3sbio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 3sbio Main Business Overview

11.14.5 3sbio Latest Developments

11.15 Gan&Lee

11.15.1 Gan&Lee Company Information

11.15.2 Gan&Lee Recombinant Protein Drug R&D Product Offered

11.15.3 Gan&Lee Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Gan&Lee Main Business Overview

11.15.5 Gan&Lee Latest Developments

11.16 Hengrui

11.16.1 Hengrui Company Information

11.16.2 Hengrui Recombinant Protein Drug R&D Product Offered

11.16.3 Hengrui Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Hengrui Main Business Overview

11.16.5 Hengrui Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Recombinant Protein Drug R&D Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Peptide Hormones

Table 3. Major Players of Hematopoietic Factor

Table 4. Major Players of Cytokines

Table 5. Major Players of Plasma Protein Factor

Table 6. Major Players of Recombinase

Table 7. Major Players of Fusion Protein

Table 8. Major Players of Other

Table 9. Recombinant Protein Drug R&D Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 10. Global Recombinant Protein Drug R&D Market Size by Type (2016-2021) & ($ Millions)

Table 11. Global Recombinant Protein Drug R&D Market Size Market Share by Type (2016-2021)

Table 12. Recombinant Protein Drug R&D Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 13. Global Recombinant Protein Drug R&D Market Size by Application (2016-2021) & ($ Millions)

Table 14. Global Recombinant Protein Drug R&D Market Size Market Share by Application (2016-2021)

Table 15. Global Recombinant Protein Drug R&D Revenue by Players (2019-2021E) & ($ Millions)

Table 16. Global Recombinant Protein Drug R&D Revenue Market Share by Players (2019-2021E)

Table 17. Recombinant Protein Drug R&D Key Players Head office and Products Offered

Table 18. Recombinant Protein Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Recombinant Protein Drug R&D Market Size by Regions 2016-2021 & ($ Millions)

Table 22. Global Recombinant Protein Drug R&D Market Size Market Share by Regions 2016-2021

Table 23. Americas Recombinant Protein Drug R&D Market Size by Country (2016-2021) & ($ Millions)

Table 24. Americas Recombinant Protein Drug R&D Market Size Market Share by Country (2016-2021)

Table 25. Americas Recombinant Protein Drug R&D Market Size by Type (2016-2021) & ($ Millions)

Table 26. Americas Recombinant Protein Drug R&D Market Size Market Share by Type (2016-2021)

Table 27. Americas Recombinant Protein Drug R&D Market Size by Application (2016-2021) & ($ Millions)

Table 28. Americas Recombinant Protein Drug R&D Market Size Market Share by Application (2016-2021)

Table 29. APAC Recombinant Protein Drug R&D Market Size by Region (2016-2021) & ($ Millions)

Table 30. APAC Recombinant Protein Drug R&D Market Size Market Share by Region (2016-2021)

Table 31. APAC Recombinant Protein Drug R&D Market Size by Type (2016-2021) & ($ Millions)

Table 32. APAC Recombinant Protein Drug R&D Market Size Market Share by Type (2016-2021)

Table 33. APAC Recombinant Protein Drug R&D Market Size by Application (2016-2021) & ($ Millions)

Table 34. APAC Recombinant Protein Drug R&D Market Size Market Share by Application (2016-2021)

Table 35. Europe Recombinant Protein Drug R&D Market Size by Country (2016-2021) & ($ Millions)

Table 36. Europe Recombinant Protein Drug R&D Market Size Market Share by Country (2016-2021)

Table 37. Europe Recombinant Protein Drug R&D Market Size by Type (2016-2021) & ($ Millions)

Table 38. Europe Recombinant Protein Drug R&D Market Size Market Share by Type (2016-2021)

Table 39. Europe Recombinant Protein Drug R&D Market Size by Application (2016-2021) & ($ Millions)

Table 40. Europe Recombinant Protein Drug R&D Market Size Market Share by Application (2016-2021)

Table 41. Middle East & Africa Recombinant Protein Drug R&D Market Size by Region (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Region (2016-2021)

Table 43. Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2016-2021) & ($ Millions)

Table 44. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Type (2016-2021)

Table 45. Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2016-2021) & ($ Millions)

Table 46. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Application (2016-2021)

Table 47. Key and Potential Regions of Recombinant Protein Drug R&D

Table 48. Key Application and Potential Industries of Recombinant Protein Drug R&D

Table 49. Key Challenges of Recombinant Protein Drug R&D

Table 50. Key Trends of Recombinant Protein Drug R&D

Table 51. Global Recombinant Protein Drug R&D Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 52. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Regions (2021-2026)

Table 53. Global Recombinant Protein Drug R&D Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 54. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Type (2021-2026)

Table 55. Global Recombinant Protein Drug R&D Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 56. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Application (2021-2026)

Table 57. Eli Lilly Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 58. Eli Lilly Recombinant Protein Drug R&D Product Offered

Table 59. Eli Lilly Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 60. Eli Lilly Main Business

Table 61. Eli Lilly Latest Developments

Table 62. Novo Nordisk Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 63. Novo Nordisk Recombinant Protein Drug R&D Product Offered

Table 64. Novo Nordisk Main Business

Table 65. Novo Nordisk Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Novo Nordisk Latest Developments

Table 67. Amgen Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 68. Amgen Recombinant Protein Drug R&D Product Offered

Table 69. Amgen Main Business

Table 70. Amgen Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Amgen Latest Developments

Table 72. Merck Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 73. Merck Recombinant Protein Drug R&D Product Offered

Table 74. Merck Main Business

Table 75. Merck Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Merck Latest Developments

Table 77. Sanofi Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 78. Sanofi Recombinant Protein Drug R&D Product Offered

Table 79. Sanofi Main Business

Table 80. Sanofi Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Sanofi Latest Developments

Table 82. Pfizer Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 83. Pfizer Recombinant Protein Drug R&D Product Offered

Table 84. Pfizer Main Business

Table 85. Pfizer Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Pfizer Latest Developments

Table 87. Roche Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 88. Roche Recombinant Protein Drug R&D Product Offered

Table 89. Roche Main Business

Table 90. Roche Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Roche Latest Developments

Table 92. Gensci Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 93. Gensci Recombinant Protein Drug R&D Product Offered

Table 94. Gensci Main Business

Table 95. Gensci Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Gensci Latest Developments

Table 97. Ankebio Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 98. Ankebio Recombinant Protein Drug R&D Product Offered

Table 99. Ankebio Main Business

Table 100. Ankebio Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. Ankebio Latest Developments

Table 102. United Cell Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 103. United Cell Recombinant Protein Drug R&D Product Offered

Table 104. United Cell Main Business

Table 105. United Cell Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. United Cell Latest Developments

Table 107. Sinobioway Hygene Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 108. Sinobioway Hygene Recombinant Protein Drug R&D Product Offered

Table 109. Sinobioway Hygene Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 110. Sinobioway Hygene Main Business

Table 111. Sinobioway Hygene Latest Developments

Table 112. Kexing Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 113. Kexing Recombinant Protein Drug R&D Product Offered

Table 114. Kexing Main Business

Table 115. Kexing Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 116. Kexing Latest Developments

Table 117. Dongbao Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 118. Dongbao Recombinant Protein Drug R&D Product Offered

Table 119. Dongbao Main Business

Table 120. Dongbao Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 121. Dongbao Latest Developments

Table 122. 3sbio Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 123. 3sbio Recombinant Protein Drug R&D Product Offered

Table 124. 3sbio Main Business

Table 125. 3sbio Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 126. 3sbio Latest Developments

Table 127. Gan&Lee Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 128. Gan&Lee Recombinant Protein Drug R&D Product Offered

Table 129. Gan&Lee Main Business

Table 130. Gan&Lee Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 131. Gan&Lee Latest Developments

Table 132. Hengrui Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors

Table 133. Hengrui Recombinant Protein Drug R&D Product Offered

Table 134. Hengrui Main Business

Table 135. Hengrui Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 136. Hengrui Latest Developments

List of Figures

Figure 1. Recombinant Protein Drug R&D Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Recombinant Protein Drug R&D Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Recombinant Protein Drug R&D Market Size Market Share by Type in 2020

Figure 7. Recombinant Protein Drug R&D in Diabetes

Figure 8. Global Recombinant Protein Drug R&D Market: Diabetes (2016-2021) & ($ Millions)

Figure 9. Recombinant Protein Drug R&D in Dwarfism

Figure 10. Global Recombinant Protein Drug R&D Market: Dwarfism (2016-2021) & ($ Millions)

Figure 11. Recombinant Protein Drug R&D in Hemophilia

Figure 12. Global Recombinant Protein Drug R&D Market: Hemophilia (2016-2021) & ($ Millions)

Figure 13. Recombinant Protein Drug R&D in Heart Disease

Figure 14. Global Recombinant Protein Drug R&D Market: Heart Disease (2016-2021) & ($ Millions)

Figure 15. Recombinant Protein Drug R&D in Cancer

Figure 16. Global Recombinant Protein Drug R&D Market: Cancer (2016-2021) & ($ Millions)

Figure 17. Recombinant Protein Drug R&D in Other

Figure 18. Global Recombinant Protein Drug R&D Market: Other (2016-2021) & ($ Millions)

Figure 19. Global Recombinant Protein Drug R&D Market Size Market Share by Application in 2020

Figure 20. Global Recombinant Protein Drug R&D Revenue Market Share by Player in 2020

Figure 21. Global Recombinant Protein Drug R&D Market Size Market Share by Regions (2016-2021)

Figure 22. Americas Recombinant Protein Drug R&D Market Size 2016-2021 ($ Millions)

Figure 23. APAC Recombinant Protein Drug R&D Market Size 2016-2021 ($ Millions)

Figure 24. Europe Recombinant Protein Drug R&D Market Size 2016-2021 ($ Millions)

Figure 25. Middle East & Africa Recombinant Protein Drug R&D Market Size 2016-2021 ($ Millions)

Figure 26. Americas Recombinant Protein Drug R&D Market Size Market Share by Country in 2020

Figure 27. Americas Recombinant Protein Drug R&D Market Size Market Share by Type in 2020

Figure 28. Americas Recombinant Protein Drug R&D Market Size Market Share by Application in 2020

Figure 29. United States Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 30. Canada Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 31. Mexico Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 32. APAC Recombinant Protein Drug R&D Market Size Market Share by Regions in 2020

Figure 33. APAC Recombinant Protein Drug R&D Market Size Market Share by Type in 2020

Figure 34. APAC Recombinant Protein Drug R&D Market Size Market Share by Application in 2020

Figure 35. China Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 36. Japan Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 37. Korea Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 38. Southeast Asia Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 39. India Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 40. Australia Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 41. Europe Recombinant Protein Drug R&D Market Size Market Share by Country in 2020

Figure 42. Europe Recombinant Protein Drug R&D Market Size Market Share by Type in 2020

Figure 43. Europe Recombinant Protein Drug R&D Market Size Market Share by Application in 2020

Figure 44. Germany Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 45. France Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 46. UK Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 47. Italy Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 48. Russia Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 49. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Region in 2020

Figure 50. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Type in 2020

Figure 51. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Application in 2020

Figure 52. Egypt Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 53. South Africa Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 54. Israel Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 55. Turkey Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 56. GCC Country Recombinant Protein Drug R&D Market Size Growth 2016-2021 ($ Millions)

Figure 57. Americas Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 58. APAC Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 59. Europe Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 60. Middle East & Africa Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 61. United States Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 62. Canada Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 63. Mexico Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 64. Brazil Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 65. China Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 66. Japan Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 67. Korea Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 68. Southeast Asia Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 69. India Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 70. Australia Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 71. Germany Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 72. France Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 73. UK Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 74. Italy Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 75. Russia Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 76. Spain Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 77. Egypt Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 78. South Africa Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 79. Israel Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 80. Turkey Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)

Figure 81. GCC Country Recombinant Protein Drug R&D Market Size 2021-2026 ($ Millions)